I'll go first. I think they lose another million on $14M in sales. freddie will guide down a couple of million for the year, but insist 4Q13 will be profitable. The middle of November may present an interesting short term buying situation around $1.50.
Given your track record, I understand why you don't want to make a prediction. That's OK. The numbers will be out Monday. We'll see if there is a short term play setting up next week.
go check out all the sec letters that were uploaded. this is from the 9/5 one. "revenue in the third quarter may be affected by vacation patterns which can cause revenue to be flat or lower than in the second quarter of the year."
From the revised loan agreement. "Company must maintain minimum EBITDA of $(1,000,000) and $1,250,000 at September 30, 2013 and December 31, 2013, respectively." I have to imagine that they will meet this being that it was reworked so late into the quarter. But if they dont hold on for a ride.
I can't believe they sell anything even close to $14 million.
What dentists want to buy from a company with a suspect future?
Parts and service might become an issue.
The weak financial condition of BIOL is certainly not a selling point.